Rain Therapeutics (RAIN) Stock Highlights

1.21 | +0%

2024-12-21 07:17:59

Rain Therapeutics Inc is a late-stage precision oncology company developing therapies that target oncogenic drivers for which it is able to genetically select patients it believes will likely benefit. This approach includes using a tumor-agnostic strategy to select patients based on their tumors underlying genetics rather than histology. The companys product candidate, milademetan, is a small molecule, oral inhibitor of MDM2, which is oncogenic in numerous cancers. In addition to milademetan, the company is also developing a preclinical program that is focused on inducing synthetic lethality in cancer cells by inhibiting RAD52.

Statistics

Range Today

1.21 1.21

Volume Today 0

Range 1 Year

0.82 11.32

Volume 1 Year 148.81M

Range 3 Year

0.82 23.9

Volume 3 Year 204.47M

Range 10 Year

0.82 23.9

Volume 10 Year 204.47M

Highlights

Market Capitalization 44.01M (micro)

Floating Shares 14.58M

Current Price 1.21

Price To Earnings -0.6

Price To Book 0.65

Earnings Per Share -2.07

Payout Ratio 0%

Performance

Latest 0%

1 Month +0.83%

3 Months +15.24%

6 Months -9.02%

1 Year -87.34%

3 Years -94.52%

5 Years -94.52%

10 Years -94.52%

Benchmarks

Market Capitalization

0 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

0 / 368

Free Cashflow

0 / 352

Performance 5 years

0 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.